People: February 2006

Whitehouse Scientific, UK, has welcomed back Jamie Storey to his role of laboratory manager following his overseas posting with the Territorial Army. Called up in 2004 to serve overseas with the Royal Fusiliers of Tynemouth, he spent time trekking to Everest base camp and following the Machu Picchu Inca trail in Peru. He has worked for the company as laboratory manager since graduating from Newcastle University in 1999.

Whitehouse Scientific, UK, has welcomed back Jamie Storey to his role of laboratory manager following his overseas posting with the Territorial Army. Called up in 2004 to serve overseas with the Royal Fusiliers of Tynemouth, he spent time trekking to Everest base camp and following the Machu Picchu Inca trail in Peru. He has worked for the company as laboratory manager since graduating from Newcastle University in 1999.

G Allen Nickols PhD, former director of pharmacology at Pfizer Global Research & Development, has been named vice-president of biology at Kereos. He will be responsible for preclinical pharmacology and will focus primarily on the in vitro and in vivo testing needed to move Kereos' imaging and chemotherapeutic agents for the detection and treatment of cancer into clinical trials in 2006.

Sir John Banham is to succeed Michael Miles as chairman of Johnson Matthey on 1 April, having joined the board as chairman designate on 1 January. He is already chairman of cancer biotech company Cyclacel, based in Dundee, Scotland, and US company Spacelabs Healthcare, of Washington, which manufactures and distributes medical devices and services.

Judith Hackitt, has left her role as director-general of the Chemical Industries Association (CIA) to become Implementation Manager on Cefic's (The European Chemical Industry Council) 'Chemistry for Europe' project. Steve Elliott, currently director of business environment at CIA, will take over as acting director-general.

Penn Pharmaceutical Services, a UK-based outsourcing provider, has appointed John Roberts to the position of director of operations. He joins from Marix Drug Development, where he was commercial director, and will be responsible at executive level for contract manufacturing, clinical trial supply and project management. Dr Rob Harris, previously director of pharmaceutical development at Quay Pharmaceuticals, has also moved to Penn. He will be the company's principal technical specialist in formulation development.

Chris Webster has been appointed as the new general manager of Albion Chemicals Group's Bristol Depot in Portishead, UK. Having previously held the role of factory manager with two major food suppliers, his new role will see him take charge of a team of 35 staff, including operations managers and sales teams, in the largest geographical area in Albion's national network.

Companies